Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2022 | Nov. 21, 2022 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2022 | |
Entity File Number | 001-40779 | |
Entity Incorporation, State or Country Code | DE | |
Entity Registrant Name | Digital World Acquisition Corp. | |
Entity Tax Identification Number | 85-4293042 | |
Entity Address, Address Line One | 3109 Grand Ave | |
Entity Address, City or Town | #450 Miami | |
Entity Address State Or Province | FL | |
Entity Address, Postal Zip Code | 33133 | |
City Area Code | 305 | |
Local Phone Number | 735-1517 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Entity Central Index Key | 0001849635 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant | |
Trading Symbol | DWACU | |
Security Exchange Name | NASDAQ | |
Class A Common Stock | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | |
Trading Symbol | DWAC | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 30,027,234 | |
Class B Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 7,187,500 | |
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 | |
Trading Symbol | DWACW | |
Security Exchange Name | NASDAQ |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash | $ 1,012 | $ 327,731 |
Prepaid assets | 227,768 | 240,972 |
Total Current Assets | 228,780 | 568,703 |
Prepaid assets | 0 | 165,051 |
Cash Held in Trust Account | 297,884,582 | 293,257,098 |
TOTAL ASSETS | 298,113,362 | 293,990,852 |
Current liabilities | ||
Accrued expenses | 11,022,242 | 483,535 |
Note payable – Sponsor | 2,875,000 | 0 |
Franchise tax payable | 350,000 | 200,000 |
Working capital loans | 581,700 | |
Total Current Liabilities | 14,828,942 | 683,535 |
Deferred underwriter fee payable | 10,062,500 | 10,062,500 |
TOTAL LIABILITIES | 24,891,442 | 10,746,035 |
Commitments and Contingencies | ||
Stockholders' Deficit | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Additional paid-in capital | ||
Accumulated deficit | (23,956,249) | (10,006,029) |
Total Stockholders' Deficit | (23,955,403) | (10,005,183) |
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS' DEFICIT | 298,113,362 | 293,990,852 |
Common Class B [Member] | ||
Stockholders' Deficit | ||
Common Stock | 719 | 719 |
Class A Common Stock Not Subject to Redemption | ||
Current liabilities | ||
Class A common stock subject to possible redemption, $0.0001 par value, 200,000,000 shares authorized; 28,750,000 shares outstanding, at redemption value | 297,177,323 | 293,250,000 |
Stockholders' Deficit | ||
Common Stock | $ 127 | $ 127 |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Preferred stock, par value (per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common shares, par value (per share) | $ 0.0001 | |
Class A Common Stock | ||
Common shares, par value (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 200,000,000 | 200,000,000 |
Common shares, shares outstanding | 1,277,234 | 1,277,234 |
Class A Common Stock Subject to Redemption | ||
Temporary equity, par value (per share) | $ 0.0001 | $ 0.0001 |
Temporary equity, shares authorized | 200,000,000 | 200,000,000 |
Temporary equity, shares outstanding | 28,750,000 | 28,750,000 |
Class A Common Stock Not Subject to Redemption | ||
Common shares, shares issued | 1,277,234 | 1,277,234 |
Common shares, shares outstanding | 1,277,234 | 1,277,234 |
Class B Common Stock | ||
Common shares, par value (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 10,000,000 | 10,000,000 |
Common shares, shares issued | 7,187,500 | 7,187,500 |
Common shares, shares outstanding | 7,187,500 | 7,187,500 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Formation and operating costs | $ 4,801,532 | $ 160,072 | $ 11,418,122 | $ 161,297 |
Loss from operation costs | (4,801,532) | (160,072) | (11,418,122) | (161,297) |
Other income and expenses: | ||||
Interest earned on cash held in Trust Account | 1,326,957 | 902 | 1,752,484 | 902 |
Loss before income taxes | (3,474,575) | (159,170) | (9,665,638) | (160,395) |
Income tax expense | (322,546) | 0 | (357,259) | 0 |
Net loss | $ (3,797,121) | $ (159,170) | $ (10,022,897) | $ (160,395) |
Class A Common Stock | ||||
Other income and expenses: | ||||
Weighted average shares outstanding, basic | 30,027,234 | 7,259,331 | 30,027,234 | 2,428,673 |
Net income per common stock, basic | $ (0.1) | $ (0.01) | $ (0.27) | $ (0.02) |
Weighted average shares outstanding, diluted | 30,027,234 | 7,259,331 | 30,027,234 | 2,428,673 |
Net income per common stock, diluted | $ (0.1) | $ (0.01) | $ (0.27) | $ (0.02) |
Class B Common Stock | ||||
Other income and expenses: | ||||
Weighted average shares outstanding, basic | 7,187,500 | 7,187,500 | 7,187,500 | 7,187,500 |
Net income per common stock, basic | $ (0.1) | $ (0.01) | $ (0.27) | $ (0.02) |
Weighted average shares outstanding, diluted | 7,187,500 | 7,187,500 | 7,187,500 | 7,187,500 |
Net income per common stock, diluted | $ (0.1) | $ (0.01) | $ (0.27) | $ (0.02) |
STATEMENTS OF CHANGES STOCKHOLD
STATEMENTS OF CHANGES STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) | Total | Additional Paid-in Capital [Member] | Accumulated Deficit | Class A Common Stock Not Subject to Redemption Common Stock [Member] | Common Class B [Member] Common Stock [Member] | |
Balance at the beginning at Dec. 31, 2020 | $ 0 | |||||
Balance at the beginning (in shares) at Dec. 31, 2020 | 0 | 0 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Issuance of Class B common stock to sponsor | [1],[2] | 25,000 | 24,281 | $ 719 | ||
Issuance of Class B common stock to sponsor (in shares) | [1],[2] | 7,187,500 | ||||
Net loss | (485) | (485) | ||||
Balance at the end at Mar. 31, 2021 | 24,515 | 24,281 | (485) | $ 0 | $ 719 | |
Balance at the end (in shares) at Mar. 31, 2021 | 0 | 7,187,500 | ||||
Balance at the beginning at Dec. 31, 2020 | $ 0 | |||||
Balance at the beginning (in shares) at Dec. 31, 2020 | 0 | 0 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net loss | (160,395) | |||||
Balance at the end at Sep. 30, 2021 | (8,781,083) | (8,781,929) | $ 127 | $ 719 | ||
Balance at the end (in shares) at Sep. 30, 2021 | 1,277,234 | 7,187,500 | ||||
Balance at the beginning at Dec. 31, 2020 | $ 0 | |||||
Balance at the beginning (in shares) at Dec. 31, 2020 | 0 | 0 | ||||
Balance at the end at Dec. 31, 2021 | (10,005,183) | (10,006,029) | $ 127 | $ 719 | ||
Balance at the end (in shares) at Dec. 31, 2021 | 1,277,234 | 7,187,500 | ||||
Balance at the beginning at Mar. 31, 2021 | 24,515 | 24,281 | (485) | $ 0 | $ 719 | |
Balance at the beginning (in shares) at Mar. 31, 2021 | 0 | 7,187,500 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net loss | (740) | (740) | ||||
Balance at the end at Jun. 30, 2021 | 23,775 | 24,281 | (1,225) | $ 0 | $ 719 | |
Balance at the end (in shares) at Jun. 30, 2021 | 0 | 7,187,500 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Class A common stock accretion to redemption value | (19,980,528) | (12,796,500) | (7,184,020) | |||
Issuance of Class A common stock to investor | 11,334,840 | 11,334,272 | $ 113 | |||
Issuance of Class A common stock to investor (in shares) | 1,133,484 | |||||
Issuance of Class A common stock to representative | 1,437,500 | (1,437,514) | $ 14 | |||
Issuance of Class A common stock to representative (in shares) | 143,750 | |||||
Net loss | (159,170) | (159,170) | ||||
Balance at the end at Sep. 30, 2021 | (8,781,083) | (8,781,929) | $ 127 | $ 719 | ||
Balance at the end (in shares) at Sep. 30, 2021 | 1,277,234 | 7,187,500 | ||||
Balance at the beginning at Dec. 31, 2021 | (10,005,183) | (10,006,029) | $ 127 | $ 719 | ||
Balance at the beginning (in shares) at Dec. 31, 2021 | 1,277,234 | 7,187,500 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net loss | (1,884,389) | (1,884,389) | ||||
Balance at the end at Mar. 31, 2022 | (11,889,572) | (11,890,418) | $ 127 | $ 719 | ||
Balance at the end (in shares) at Mar. 31, 2022 | 1,277,234 | 7,187,500 | ||||
Balance at the beginning at Dec. 31, 2021 | (10,005,183) | (10,006,029) | $ 127 | $ 719 | ||
Balance at the beginning (in shares) at Dec. 31, 2021 | 1,277,234 | 7,187,500 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net loss | (10,022,897) | |||||
Balance at the end at Sep. 30, 2022 | (23,955,403) | 0 | (23,956,249) | $ 127 | $ 719 | |
Balance at the end (in shares) at Sep. 30, 2022 | 1,277,234 | 7,187,500 | ||||
Balance at the beginning at Mar. 31, 2022 | (11,889,572) | (11,890,418) | $ 127 | $ 719 | ||
Balance at the beginning (in shares) at Mar. 31, 2022 | 1,277,234 | 7,187,500 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Class A common stock accretion to redemption value | (32,625) | (32,625) | ||||
Net loss | (4,341,387) | (4,341,387) | ||||
Balance at the end at Jun. 30, 2022 | (16,263,584) | 0 | (16,264,430) | $ 127 | $ 719 | |
Balance at the end (in shares) at Jun. 30, 2022 | 1,277,234 | 7,187,500 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Class A common stock accretion to redemption value | (1,019,698) | (1,019,698) | ||||
Net loss | (3,797,121) | (3,797,121) | ||||
Contribution from sponsor | (2,875,000) | (2,875,000) | ||||
Balance at the end at Sep. 30, 2022 | $ (23,955,403) | $ 0 | $ (23,956,249) | $ 127 | $ 719 | |
Balance at the end (in shares) at Sep. 30, 2022 | 1,277,234 | 7,187,500 | ||||
[1]On September 2, 2021, the Sponsor surrendered an aggregate of 1,437,500 shares of Class B common stock for no consideration, resulting in an aggregate of 7,187,500 shares of Class B common stock issued and outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender of these shares (see Note 7).[2]The shares and the associated amounts have been retroactively restated to reflect the three-for-one stock split on July 1, 2021. |
STATEMENTS OF CHANGES STOCKHO_2
STATEMENTS OF CHANGES STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) | Jul. 01, 2021 |
Common Class B [Member] | |
Stock split | 3 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Cash flows from operating activities: | ||
Net loss | $ (10,022,897) | $ (160,395) |
Adjustments to reconcile net income to net cash used in operating activities: | ||
Interest earned on cash and marketable securities held in Trust Account | (1,752,484) | (902) |
Changes in operating assets and liabilities: | ||
Accrued expenses paid by promissory note | 0 | 485 |
Accrued expenses | 10,538,707 | 54,075 |
Due to related party | 11,000 | |
Prepaid insurance | 178,255 | 0 |
Franchise tax payable | 150,000 | 149,042 |
Net cash (used in) provided by operating activities | (908,419) | 52,820 |
Cash flows from investing activities: | ||
Investment of cash in Trust Account | (2,875,000) | (293,250,000) |
Net cash used in investing activities | (2,875,000) | (293,250,000) |
Cash flows from financing activities: | ||
Proceeds from sale of Units | 0 | 287,500,000 |
Proceeds from sale of private placement warrants | 0 | 11,334,840 |
Proceeds from Sponsor note | 2,875,000 | 223,557 |
Repayment of Sponsor note | 0 | (223,557) |
Due from Sponsor | 0 | (1,702,958) |
Payment of due from Sponsor | 0 | 1,702,958 |
Payment of offering costs | 0 | (4,168,028) |
Proceeds from working capital loan | 581,700 | 0 |
Proceeds from issuance of Class B common stock to Sponsor | 0 | 25,000 |
Net cash provided by financing activities | 3,456,700 | 294,691,812 |
Net change in cash | (326,719) | 1,494,632 |
Cash at beginning of period | 327,731 | 0 |
Cash at end of period | 1,012 | 1,494,632 |
Non-cash investing and financing activities: | ||
Deferred underwriting fee payable | 0 | 10,062,500 |
Remeasurement of Class A common stock | $ 1,052,323 | $ 0 |
DESCRIPTION OF ORGANIZATION AND
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Digital World Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on December 11, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on middle-market emerging growth technology-focused companies in the Americas, in the SaaS and Technology or Fintech and Financial Services sector. A s of non-operating The registration statement for the Company’s Initial Public Offering was declared effective on September 2, 2021 (the “Registration Statement”). On September 8, 2021, the Company consummated the Initial Public Offering of 28,750,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $287,500,000, and incurred offering costs of $23,566,497, consisting of deferred underwriting commissions of $10,062,500 (see Note 3), fair value of the representative shares (as defined in Note 7) of $1,437,500, fair value of shares issued to the anchor investors of the Company’s Initial Public Offering of $7,677,450, fair value of shares transferred to officers and directors of $221,018, and other offering costs of $4,168,029. The Units sold in the Initial Public Offering included Units that were subject to a 45-day Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 1,133,484 units (the “Placement Units”) at a price of $10.00 per Placement Unit in a private placement (“Private Placement”) to the Company’s sponsor, ARC Global Investments II LLC (the “Sponsor”), generating gross proceeds of $11,334,840, which is described in Note 4. Following the closing of the Initial Public Offering on September 8, 2021, an amount of $293,250,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Placement Units was placed in a trust account (the “Trust Account”) located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds meeting the conditions of paragraph (d) of Rule 2a-7 pre-Business The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination, unless otherwise required by applicable law, regulation or stock exchange rules. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s Amended and Restated Certificate of Incorporation. In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, 470-20. 480-10-S99. paid-in If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor and the Company’s officers and directors have agreed (a) to vote any shares of Class B common stock of the Company (the “Founder Shares”), the shares of Class A common stock included within the Placement Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) waive their redemption rights with respect to any Founder Shares, Private Shares held by them and any Public Shares purchased during or after the Initial Public Offering in connection with the completion of the Business Combination, (c) not to waive their redemption rights with respect to any Founder Shares, Private Shares held by them and any Public Shares purchased during or after the Initial Public Offering in connection with a stockholder vote to approve an amendment to the Amended and Restated Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or certain amendments to its Amended and Restated Certificate of Incorporation prior thereto or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the Combination Period or (B) with respect to any other provision relating to stockholders’ rights or pre-initial The Company has filed a definitive proxy statement dated August 25, 2022 with the SEC to hold a special meeting of its stockholders (the “Extension Meeting”) for approval to further amend the Company’s Amended and Restated Certificate of Incorporation (the “Extension Amendment”) to extend the period of time for completing an initial Business Combination, in three-month increments, until September 8, 2023 or such earlier date as determined by the Company’s Board of Directors. The Extension Amendment would effectively provide for an additional six months, past the two three-month extensions permitted by the Company’s existing governing documents, to complete an initial Business Combination. The Extension Meeting was originally scheduled for September 6, 2022 and was adjourned to September 8, 2022, October 10, 2022, November 3, 2022 and November 22, 2022. The Company h as five The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.20 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third - Going Concern Consideration Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of September 30, 2022 and December 31, 2021, $581,700 and $0 were outstanding under Working Capital Loans, respectively. In November 2021, the Sponsor committed to provide loans (the “November 21, 2021 Commitment”) September non-interest In November 2022, the Sponsor amended the November 2021 Commitment to provide loans of up to an aggregate of $1,000,000 to the Company through December 8, 2022, which loans will be non-interest bearing, unsecured and will be payable upon the consummation of a Business Combination. However, in connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Account Standards Update (“ASU”) 2014-15, Proposed Business Combination The Company entered into an Agreement and Plan of Merger, dated as of October 20, 2021 (as amended by the First Amendment to Agreement and Plan of Merger, dated May 11, 2022, and as it may be further amended or supplemented from time to time, the “Merger Agreement”) with DWAC Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), Trump Media & Technology Group Corp., a Delaware corporation (“TMTG”), the Sponsor, in the capacity as the representative for certain stockholders of the Company, and TMTG’s General Counsel, in the capacity as the representative for stockholders of TMTG. Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein, (i) upon the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub will merge with and into TMTG (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Transactions”), with TMTG continuing as the surviving corporation in the Merger and a wholly-owned subsidiary of the Company. In the Merger, (i) all shares of TMTG common stock (together, “TMTG Stock”) issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than those properly exercising any applicable dissenters rights under Delaware law) will be converted into the right to receive the Merger Consideration (as defined below); (ii) each outstanding option to acquire shares of TMTG common stock (whether vested or unvested) will be assumed by the Company and automatically converted into an option to acquire shares of the Company common stock, with its price and number of shares equitably adjusted based on the conversion ratio of the shares of TMTG common stock into the Merger Consideration and (iii) each outstanding restricted stock unit of TMTG shall be converted into a restricted stock unit relating to shares of the Company’s common stock. At the Closing, the Company will change its name to “Trump Media & Technology Group Corp.” The aggregate merger consideration to be paid pursuant to the Merger Agreement to holders of TMTG Stock as of immediately prior to the Effective Time (“TMTG Stockholders” and, together with the holders of TMTG options and restricted stock units immediately prior to the Effective Time, the “TMTG Security Holders”) will be an amount equal to $875,000,000, subject to adjustments for TMTG’s closing debt, net of cash and unpaid transaction expenses (the “Merger Consideration”), plus the additional contingent right to receive certain earnout shares after the Closing, provided that it shall exclude any additional shares issuable upon conversion of certain TMTG convertible notes. The Merger Consideration to be paid to TMTG Stockholders will be paid solely by the delivery of new shares of the Company’s common stock, with each valued at the price per share at which each share of the Company’s common stock is redeemed or converted pursuant to the redemption by the Company of its public stockholders in connection with the Company’s initial Business Combination, as required by the Company’s Amended and Restated Certificate of Incorporation, by-laws On December 4, 2021, in support of the Transactions, the Company entered into securities purchase agreements (the “SPAs”) with certain institutional accredited investors (the “PIPE Investors”), pursuant to which the investors agreed to purchase an aggregate of 1,000,000 shares of the Company’s Series A Convertible Preferred Stock (the “Preferred Stock”), at a purchase price of $1,000 per share of Preferred Stock, for an aggregate commitment of $1,000,000,000 in a private placement (the “PIPE”) to be consummated concurrently with the Transactions. The shares of Preferred Stock have an initial conversion price per share of $33.60 and are initially convertible into an aggregate of 29,761,905 shares of common stock. The closing of the PIPE is conditioned on the concurrent closing of the Transactions and other closing conditions as set forth in the SPA. Pursuant to the SPAs, each of the PIPE Investors may terminate its respective SPA, among other things, if the closing of the PIPE has not occurred on or prior to September 20, 2022. Between September 19, 2022 and September 23, 2022, the Company received termination notices from PIPE Investors representing approximately $138.5 million of the PIPE. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X In the opinion of the Company’s management, the unaudited financial statements as of September 30, 2022 and for the three and nine months ended September 30, 2022 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of September 30, 2022 and its results of operations and cash flows for the three and nine months ended September 30, 2022. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2022 or any future interim period. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Offering Costs Associated with the Initial Public Offering Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. These costs were charged to stockholders’ equity upon the completion of the Initial Public Offering. On September 8, 2021, offering costs in the aggregate of $15,668,029 were charged to stockholders’ equity (consisting of deferred underwriting commission of $10,062,500, fair value of the representative shares of $1,437,500 and other cash offering costs of $4,168,029). Class A Common Stock Subject to Possible Redemption As discussed in Note 3, all of the 28,750,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Certificate of Incorporation. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not September The Company has identified the United States and Florida as major tax jurisdictions. The Company is subject to examination by these taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The effective tax rate was ( ) ( ) % Net Loss Per Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period. The Company applies the two-class The calculation of diluted loss per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2022 and September 30, 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic net loss per common share for the periods presented. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued non-current net-cash 815-40. Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury Department”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 9 Months Ended |
Sep. 30, 2022 | |
INITIAL PUBLIC OFFERING | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING On September 8, 2021, the Company consummated its Initial Public Offering of 28,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287,500,000. Each Unit consists of one share of Class A common stock and one As of September 8, 2021, the Company incurred offering costs of approximately $15,668,029, consisting of deferred underwriting commissions of $10,062,500, fair value of representative shares of $1,437,500 and other offering costs of $4,168,029. |
PRIVATE PLACEMENT
PRIVATE PLACEMENT | 9 Months Ended |
Sep. 30, 2022 | |
PRIVATE PLACEMENT | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 1,133,484 Placement Units at a price of $10.00 per Placement Unit (or $11,334,840 in the aggregate). The Sponsor initially transferred $13,203,590 to the Trust Account on September 8, 2021. The excess proceeds ($1,869,110) over the proceeds of the Private Placement were transferred back to the Company’s operating account and returned to the Sponsor. The proceeds from the sale of the Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. The Placement Units are identical to the Units sold in the Initial Public Offering, except that the Placement Units and their component securities will not be transferable, assignable or salable until 30 days after the consummation of the initial Business Combination except to permitted transferees and are entitled to registration rights. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the warrants included in the Placement Units (the “Placement Warrants”) will expire worthless. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Class B Common stock During the year ended December 31, 2021, the Company issued an aggregate of 8,625,000 shares of Class B common stock or Founder Shares to the Sponsor for an aggregate purchase price of $25,000 in cash. On July 2, 2021, the Sponsor transferred 10,000 Founder Shares to its Chief Financial Officer and 7,500 Founder Shares to each of its independent directors. The Company estimated the fair value of these transferred shares to be $221,000. On September 2, 2021, the Sponsor surrendered to the Company an aggregate of 1,437,500 shares of Class B common stock for cancellation for no consideration, resulting in an aggregate of 7,187,500 shares of Class B common stock issued and outstanding. The number of Founder Shares issued represented 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the initial stockholders do not purchase any Public Shares in the Initial Public Offering and excluding the Placement Units and underlying securities). All shares and associated amounts have been retroactively restated to reflect the surrender of these shares. With certain limited exceptions, the shares of Class B common stock are not transferable, assignable by the Sponsor until the earlier to occur of: (A) six months after the completion of the Company’s initial Business Combination and (B) subsequent to the Company’s initial Business Combination, (x) if the reported last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Administrative Services Arrangement An affiliate of the Sponsor has agreed, commencing from the date when the Company’s Registration Statement was declared effective through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay the affiliate of the Sponsor $15,000 per month for these services. $45,000 and $135,000 of expense was recorded for the three and nine months ended September 30, 2022, respectively. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, initially up to $1,500,000 of notes could have been converted upon consummation of a Business Combination into additional units at a price of $10.00 per unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. In November 2021, the Sponsor committed to provide loans of up to an aggregate of $1,000,000 to the Company through September 8, 2022 (or up to March 8, 2023 if the Company extends the maximum time to complete a Business Combination), which loans will be non-interest In November 2022, the Sponsor amended the November 2021 Commitment to provide loans of up to an aggregate of $1,000,000 to the Company through December 8, 2022, which loans will be non-interest bearing, unsecured and will be payable upon the consummation of a Business Combination. On May 12, 2022, the Company entered into an amendment (the “Amendment to the Insider Letter”) to that certain letter agreement, dated September 2, 2021 (“Insider Letter”), with the Sponsor and the Company’s directors, officers or other initial shareholders named therein (the “Insiders”). Pursuant to the Insider Letter, among other matters, the Sponsor and the Insiders agreed in Section 9 thereof, that the Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may make non-interest On September 8, 2022, the Company issued a promissory note (the “Note”) in the aggregate principal amount of $2,875,000 to the Sponsor, in connection with the extension of the termination date for the Company’s initial Business Combination from September 8, 2022 to December 8, 2022. The Note bears no interest and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of the Sponsor and subject to certain conditions, all of the unpaid principal amount of the Note may be converted into units of the Company (the “Conversion Units”) upon consummation of the i outstanding under this Note. The Company has filed a definitive proxy statement dated August 25, 2022 with the SEC to hold an Extension Meeting for approval of the Extension Amendment to extend the period of time for completing an initial Business Combination, in three-month increments, until September 8, 2023 or such earlier date as determined by the Company’s Board of Directors. The Extension Amendment would effectively provide for an additional six months, past the two three-month extensions permitted by the Company’s existing governing documents, to complete an initial Business Combination. The Extension Meeting was originally scheduled for September 6, 2022 and was adjourned to September 8, 2022, October 10, 2022, November 3, 2022 and November 22, 2022. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 6. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, the holders of representative shares as well as the holders of the Placement Units (and underlying securities) and any securities issued in payment of Working Capital Loans made to the Company, are entitled to registration rights pursuant to an agreement signed on the effective date of the Initial Public Offering. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. Notwithstanding anything to the contrary, the underwriters (and/or their designees) may participate in a “piggy-back” registration only during the seven year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Notwithstanding anything to the contrary, under FINRA Rule 5110, the underwriters and/or their designees may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the registration statement relating to the Initial Public Offering, and the underwriters and/or their designees may participate in a “piggy- back” registration only during the seven-year period beginning on the effective date of the registration statement relating to the Initial Public Offering. Underwriting Agreement The underwriters purchased the 3,750,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The underwriters are entitled to a cash underwriting discount of: (i) one point twenty-five percent (1.25%) of the gross proceeds of the Initial Public Offering, or $3,593,750, with the underwriters’ over-allotment having been exercised in full; (ii) zero point five percent (0.50%) of the total number of shares of Class A common stock issued in the Initial Public Offering, or 143,750 shares of Class A common stock. In addition, the underwriters are entitled to a deferred underwriting commissions of three point five percent (3.50%) of the gross proceeds of the Initial Public Offering, or $10,062,500 upon closing of the Business Combination. The deferred underwriting commissions will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. Right of First Refusal Subject to certain conditions, the Company granted the underwriter, for a period of 24 months after the date of the consummation of the Business Combination, a right of first refusal to act as sole book runner, and/or sole placement agent, at the representative’s sole discretion, for each and every future public and private equity and debt offering, including all equity linked financings for the Company or any of its successors or subsidiaries. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three years from the effective date of the Registration Statement. Legal Matters The Company is cooperating with a Financial Industry Regulatory Authority, Inc. (“FINRA”) inquiry concerning events (specifically, a review of trading) that preceded the public announcement of the Merger Agreement. According to FINRA’s request, the inquiry should not be construed as an indication that FINRA has determined that any violations of Nasdaq rules or federal securities laws have occurred, nor as a reflection upon the merits of the securities involved or upon any person who effected transactions in such securities. The Company is also cooperating with an SEC investigation, including responding to several document requests and subpoenas from the SEC to the Company and certain of its directors seeking various documents and information regarding, among other things, meetings of the Company’s Board of Directors; communications with and the evaluation of potential targets, including TMTG; communications relating to TMTG; agreements with and payments made to certain advisors; investors, including investor meetings and agreements; the appointment of certain of the Company’s officers and directors; policies and procedures relating to trading; and documents sufficient to identify banking, telephone, and email addresses; the Company’s due diligence regarding TMTG, communications regarding and due diligence of potential targets other than TMTG; and relationships between and among the Company (and/or certain of its officers and directors) and other entities (including the Sponsor and certain advisors, including the Company’s underwriter and financial advisor in its Initial Public Offering). According to the SEC’s request and subpoena, the investigation does not mean that the SEC has concluded that anyone violated the law or that the SEC has a negative opinion of the Company or any person, entity, or security. Any resolution of the inquiry or investigation, as well as proceedings by the SEC, FINRA, or other governmental or regulatory authorities, could result in the imposition of significant fines, penalties, injunctions, prohibitions on the conduct of the Company’s business, damage to its reputation and other sanctions against it, including restrictions on its activities. The SEC also issued an order of examination pursuant to Section 8(e) of the Securities Act, with respect to the Form S-4 S-4. S-4 S-4, In addition, the Company and each member of its board of directors received grand jury subpoenas seeking certain of the same documents demanded in the above-referenced SEC subpoenas, along with requests relating to the Company’s S-1 These subpoenas, and the underlying investigations by the SEC and the U.S. Department of Justice, can be expected to delay effectiveness of the Form S-4, |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 9 Months Ended |
Sep. 30, 2022 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS' EQUITY | NOTE 7. STOCKHOLDERS’ EQUITY Preferred Stock - The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding. Class A Common Stock - The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. On September 8, 2021, the Company issued 143,750 shares of Class A common stock (“representative shares”) to the underwriter. The Company accounts for the representative shares as an expense of the Initial Public Offering resulting in a charge directly to stockholders’ equity, at an estimated fair value of $1,437,500. At September Class B Common Stock - The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s Class B common stock are entitled to one vote for each share. On September 2, 2021, the Sponsor surrendered an aggregate of 1,437,500 shares of Class B common stock for cancellation for no consideration. At September 30, 2022 and December 31, 2021, there were 7,187,500 shares of Class B common stock issued and outstanding, of which 1,650,000 shares were transferred to qualified institutional buyers. The shares of Class B Common Stock held by the Sponsor, officers and directors of the Company and institutional buyers represent 20% of the issued and outstanding shares after the Initial Public Offering (assuming those initial stockholders do not purchase any Public Shares in the Initial Public Offering and excluding the Placement Shares). Shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one Warrants - The warrants will become exercisable 30 days after the consummation of a Business Combination. The warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of Class A common stock issuable upon exercise of the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. Once the warrants become exercisable, the Company may redeem the warrants: • in whole and not in part; • at a price of $0.01 per warrant; • at any time after the warrants become exercisable; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; • if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, and recapitalizations) for any 20 trading days within a 30-trading • if, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants. If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities, for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the sponsor or its affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. The Private Warrants, as well as any warrants underlying additional units the Company issues to the Sponsor, officers, directors, initial stockholders or their affiliates in payment of Working Capital Loans made to the Company, will be identical to the Public Warrants and may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination and will be entitled to registration rights. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2022 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 8. SUBSEQUENT EVENTS In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2022, up to the date the Company issued the financial statements. Based upon this review , except as noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. In November 2022, the Sponsor committed to provide loans of up to an aggregate of $1,000,000 to the Company through December 8, 2022, which loans will be non-interest bearing, unsecured and will be payable upon the consummation of a Business Combination. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X In the opinion of the Company’s management, the unaudited financial statements as of September 30, 2022 and for the three and nine months ended September 30, 2022 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of September 30, 2022 and its results of operations and cash flows for the three and nine months ended September 30, 2022. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2022 or any future interim period. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. These costs were charged to stockholders’ equity upon the completion of the Initial Public Offering. On September 8, 2021, offering costs in the aggregate of $15,668,029 were charged to stockholders’ equity (consisting of deferred underwriting commission of $10,062,500, fair value of the representative shares of $1,437,500 and other cash offering costs of $4,168,029). |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption As discussed in Note 3, all of the 28,750,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Certificate of Incorporation. |
Income Taxes | Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not September The Company has identified the United States and Florida as major tax jurisdictions. The Company is subject to examination by these taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The effective tax rate was ( ) ( ) % |
Net Loss Per Share | Net Loss Per Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period. The Company applies the two-class The calculation of diluted loss per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2022 and September 30, 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic net loss per common share for the periods presented. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued non-current net-cash 815-40. |
Recently Issued Accounting Standards | Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. |
Risks and Uncertainties | Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 |
Inflation Reduction Act of 2022 | Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury Department”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. |
DESCRIPTION OF ORGANIZATION A_2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) | 3 Months Ended | 9 Months Ended | ||||||||||
Sep. 23, 2022 USD ($) | Sep. 19, 2022 USD ($) | Dec. 04, 2021 USD ($) $ / shares shares | Sep. 08, 2021 USD ($) $ / shares shares | Mar. 31, 2021 USD ($) | Sep. 30, 2022 USD ($) d | Sep. 30, 2021 USD ($) | Nov. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) | Nov. 30, 2021 USD ($) | Oct. 20, 2021 USD ($) | ||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Condition for future business combination number of businesses minimum | d | 1 | |||||||||||
Payments for investment of cash in trust account | $ 2,875,000 | $ 293,250,000 | ||||||||||
Obligation to redeem Public Shares if entity does not complete a business combination within the combination period (as a percent) | 100% | |||||||||||
Minimum net tangible assets upon consummation of the business combination | $ 5,000,001 | |||||||||||
Redemption limit percentage without prior consent | 15 | |||||||||||
Minimum net tangible assets required to be maintained upon redemption of public shares | $ 5,000,001 | |||||||||||
Redemption period upon closure | 5 days | |||||||||||
Maximum allowed dissolution expenses | $ 100,000 | |||||||||||
Stock issued during period, value, new issues | [1],[2] | $ 25,000 | ||||||||||
Working capital loans | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Outstanding balance | $ 581,700 | $ 0 | ||||||||||
Initial Public Offering | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Deferred underwriting commissions | $ 10,062,500 | |||||||||||
Number of units sold | shares | 28,750,000 | |||||||||||
Fair value of the representative shares | $ 1,437,500 | |||||||||||
Other offering costs | $ 4,168,029 | |||||||||||
Purchase price, per unit | $ / shares | $ 10 | |||||||||||
Proceeds from Issuance Initial Public Offering | $ 287,500,000 | |||||||||||
Offering costs | 23,566,497 | |||||||||||
Payments for investment of cash in trust account | $ 293,250,000 | |||||||||||
Payments for investment of cash in trust account, per unit | $ / shares | $ 10.2 | |||||||||||
Stock issued during period, Value, Issued for services | $ 7,677,450 | |||||||||||
Share transfer between related parties, Value | $ 221,018 | |||||||||||
Over-Allotment Option [Member] | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Number of units sold | shares | 3,750,000 | |||||||||||
Underwriting option period | 45 days | |||||||||||
Merger agreement with TMTG | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Agreed consideration | $ 875,000,000 | |||||||||||
True up period after the closing | 90 days | |||||||||||
Sponsor | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Working Capital Loan Warrant | $ 1,000,000 | $ 1,000,000 | ||||||||||
Sponsor | Initial Public Offering | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Number of units sold | shares | 1,133,484 | |||||||||||
Sponsor | Private Placement | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Number of units sold | shares | 1,133,484 | |||||||||||
Purchase price, per unit | $ / shares | $ 10 | |||||||||||
Gross proceeds from sale of units | $ 11,334,840 | |||||||||||
Sponsor | Subsequent Event [Member] | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Working Capital Loan Warrant | $ 1,000,000 | |||||||||||
Sponsor | Subsequent Event [Member] | Amended November 2021 Commitment | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Working Capital Loan Warrant | $ 1,000,000 | |||||||||||
PIPE Investors [Member] | Security Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member] | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Preferred stock, convertible, conversion price | $ / shares | $ 33.6 | |||||||||||
PIPE Investors [Member] | Security Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member] | Common Stock [Member] | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Conversion of stock, shares converted | shares | 29,761,905 | |||||||||||
PIPE Investors [Member] | Private Placement | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Termination notices from Investors | $ 138,500,000 | $ 138,500,000 | ||||||||||
PIPE Investors [Member] | Private Placement | Security Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member] | ||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||
Purchase price, per unit | $ / shares | $ 1,000 | |||||||||||
Number of shares issued | shares | 1,000,000 | |||||||||||
Stock issued during period, value, new issues | $ 1,000,000,000 | |||||||||||
[1]On September 2, 2021, the Sponsor surrendered an aggregate of 1,437,500 shares of Class B common stock for no consideration, resulting in an aggregate of 7,187,500 shares of Class B common stock issued and outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender of these shares (see Note 7).[2]The shares and the associated amounts have been retroactively restated to reflect the three-for-one stock split on July 1, 2021. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 08, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Unrecognized Tax Benefits | $ 0 | $ 0 | $ 0 | |||
Unrecognized tax benefits accrued for interest and penalties | 0 | 0 | $ 0 | |||
Federal depository insurance coverage | $ 250,000 | $ 250,000 | ||||
Effective tax rate | 9.30% | 0% | 3.70% | 0% | ||
Initial Public Offering | ||||||
Offering costs | $ 15,668,029 | |||||
Deferred underwriting commissions | 10,062,500 | |||||
Fair value of the representative shares | 1,437,500 | |||||
Other offering costs | $ 4,168,029 | |||||
Class A Common Stock Subject to Redemption | Initial Public Offering | ||||||
Number of shares issued | 28,750,000 |
INITIAL PUBLIC OFFERING - Addit
INITIAL PUBLIC OFFERING - Additional Information (Details) - Initial Public Offering | Sep. 08, 2021 USD ($) $ / shares shares |
Subsidiary, Sale of Stock [Line Items] | |
Number of units sold | shares | 28,750,000 |
Purchase price, per unit | $ / shares | $ 10 |
Proceeds from Issuance Initial Public Offering | $ 287,500,000 |
Number of warrants in a unit | shares | 0.5 |
Offering costs | $ 15,668,029 |
Deferred underwriting commissions | 10,062,500 |
Fair value of the representative shares | 1,437,500 |
Other offering costs | $ 4,168,029 |
Class A Common Stock | |
Subsidiary, Sale of Stock [Line Items] | |
Number of shares in a unit | shares | 1 |
Class A Common Stock | Public Warrants | |
Subsidiary, Sale of Stock [Line Items] | |
Number of shares issuable per warrant | shares | 1 |
Exercise price of warrants | $ / shares | $ 11.5 |
PRIVATE PLACEMENT - Additional
PRIVATE PLACEMENT - Additional Information (Details) - USD ($) | 9 Months Ended | |
Sep. 08, 2021 | Sep. 30, 2022 | |
Subsidiary, Sale of Stock [Line Items] | ||
Restrictions on transfer period of time after business combination completion | 30 days | |
Private Placement [Member] | ||
Subsidiary, Sale of Stock [Line Items] | ||
Restrictions on transfer period of time after business combination completion | 30 days | |
Private Placement [Member] | Sponsor | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units sold | 1,133,484 | |
Purchase price, per unit | $ 10 | |
Gross proceeds from sale of units | $ 11,334,840 | |
Cash deposited into Trust Account by related party | 13,203,590 | |
Exceeds proceeds allocated over the proceeds of the Private Placement | $ 1,869,110 | |
IPO [Member] | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units sold | 28,750,000 | |
Purchase price, per unit | $ 10 | |
IPO [Member] | Sponsor | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units sold | 1,133,484 |
RELATED PARTY TRANSACTIONS - Fo
RELATED PARTY TRANSACTIONS - Founder Shares (Details) | 9 Months Ended | |||
Sep. 02, 2021 shares | Jul. 02, 2021 USD ($) shares | Sep. 30, 2022 USD ($) Day $ / shares shares | Dec. 31, 2021 shares | |
Related Party Transaction [Line Items] | ||||
Restrictions on transfer period of time after business combination completion | 30 days | |||
Class B Common Stock | ||||
Related Party Transaction [Line Items] | ||||
Numbers of shares surrendered for no consideration | 1,437,500 | |||
Common shares, shares issued | 7,187,500 | 7,187,500 | 7,187,500 | |
Common shares, shares outstanding | 7,187,500 | 7,187,500 | 7,187,500 | |
Sponsor | Class B Common Stock | ||||
Related Party Transaction [Line Items] | ||||
Numbers of shares surrendered for no consideration | 1,437,500 | |||
Founder Shares | Sponsor | Class B Common Stock | ||||
Related Party Transaction [Line Items] | ||||
Number of shares issued | 8,625,000 | |||
Aggregate purchase price | $ | $ 25,000 | |||
Numbers of shares surrendered for no consideration | 1,437,500 | |||
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders | 20% | |||
Restrictions on transfer period of time after business combination completion | 6 months | |||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 12 | |||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | Day | 20 | |||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | Day | 30 | |||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | |||
Share transfer between related parties, Value | $ | $ 221,000 | |||
Founder Shares | Sponsor | Class B Common Stock | Chief Financial Officer [Member] | ||||
Related Party Transaction [Line Items] | ||||
Number of shares transferred by sponsor | 10,000 | |||
Founder Shares | Sponsor | Class B Common Stock | Director [Member] | ||||
Related Party Transaction [Line Items] | ||||
Number of shares transferred by sponsor | 7,500 |
RELATED PARTY TRANSACTIONS - Ad
RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||
Sep. 08, 2022 | May 12, 2022 | Sep. 30, 2022 | Sep. 30, 2022 | Nov. 30, 2022 | Dec. 31, 2021 | Nov. 30, 2021 | |
Related Party Transaction [Line Items] | |||||||
Due to related parties current | $ 581,700 | $ 581,700 | |||||
Administrative Support Agreement | |||||||
Related Party Transaction [Line Items] | |||||||
Expenses per month | 15,000 | ||||||
Expenses recorded | 45,000 | 135,000 | |||||
Related Party Loans | |||||||
Related Party Transaction [Line Items] | |||||||
Due to related party | 0 | 0 | |||||
Working capital loans | |||||||
Related Party Transaction [Line Items] | |||||||
Maximum loans convertible into units | $ 1,500,000 | $ 1,500,000 | |||||
Price per unit | $ 10 | $ 10 | |||||
Sponsor | |||||||
Related Party Transaction [Line Items] | |||||||
Working Capital Loan Warrant | $ 1,000,000 | $ 1,000,000 | $ 1,000,000 | ||||
Debt instrument convertible into warrants | $ 1,500,000 | ||||||
Debt instrument interest rate | 0% | ||||||
Debt instrument conversion price | $ 10 | ||||||
Outstanding | $ 2,875,000 | $ 2,875,000 | |||||
Sponsor | Maximum [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Due to related parties current | $ 30,000,000 | ||||||
Sponsor | Minimum [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Due to related parties current | $ 1,500,000 | ||||||
Sponsor | Note [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument interest rate | 0% | ||||||
Debt instrument conversion price | $ 10 | ||||||
Debt instrument face amount | $ 2,875,000 | ||||||
Debt instrument payment terms | repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective | ||||||
Sponsor | Subsequent Event [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Working Capital Loan Warrant | $ 1,000,000 | ||||||
Sponsor | Subsequent Event [Member] | Amended November 2021 Commitment | |||||||
Related Party Transaction [Line Items] | |||||||
Working Capital Loan Warrant | $ 1,000,000 |
COMMITMENTS AND CONTINGENCIES -
COMMITMENTS AND CONTINGENCIES - Additional Information (Details) | 9 Months Ended | |
Sep. 08, 2021 shares | Sep. 30, 2022 USD ($) d shares | |
Subsidiary, Sale of Stock [Line Items] | ||
Maximum number of demands for registration of securities | d | 3 | |
Percentage of cash underwriting discount based on gross proceeds from IPO | (1.25%) | |
Aggregate cash underwriting discount if over-allotment is exercised in full | $ | $ 3,593,750 | |
Percentage of deferred underwriting commission based on gross proceeds from IPO | (3.50%) | |
Deferred underwriting commission | $ | $ 10,062,500 | |
Period of right of first refusal from the closing of business combination | 24 months | |
Common Class A [Member] | ||
Subsidiary, Sale of Stock [Line Items] | ||
Percentage of shares issuable based on stock issued in IPO | (0.50%) | |
Number of shares issuable | shares | 143,750 | |
Over-Allotment Option [Member] | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units sold | shares | 3,750,000 |
STOCKHOLDERS' EQUITY - Preferre
STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Stockholders' Equity Note [Abstract] | ||
Preferred shares, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred shares, shares issued | 0 | 0 |
Preferred shares, shares outstanding | 0 | 0 |
STOCKHOLDERS' EQUITY - Common S
STOCKHOLDERS' EQUITY - Common Stock Shares (Details) | 9 Months Ended | 12 Months Ended | |||
Sep. 02, 2021 shares | Sep. 30, 2022 USD ($) Vote $ / shares shares | Dec. 31, 2021 $ / shares shares | Jun. 30, 2022 shares | Sep. 08, 2021 shares | |
Class of Stock [Line Items] | |||||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | ||||
Class A Common Stock Not Subject to Redemption | |||||
Class of Stock [Line Items] | |||||
Common shares, shares outstanding (in shares) | 1,277,234 | 1,277,234 | |||
Class A Common Stock Subject to Redemption | |||||
Class of Stock [Line Items] | |||||
Class A common stock subject to possible redemption, outstanding (in shares) | 28,750,000 | 28,750,000 | 28,750,000 | ||
Class A Common Stock | |||||
Class of Stock [Line Items] | |||||
Common shares, shares authorized (in shares) | 200,000,000 | 200,000,000 | |||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |||
Common shares, votes per share | Vote | 1 | ||||
Common shares, shares outstanding (in shares) | 1,277,234 | 1,277,234 | |||
Class A common stock subject to possible redemption, issued (in shares) | 28,750,000 | 28,750,000 | 143,750 | ||
Issuance of Class A common stock to representative | $ | $ 1,437,500 | ||||
Issuance of Class A common stock to representative (in shares) | 1,277,234 | 1,277,234 | |||
Class B Common Stock | |||||
Class of Stock [Line Items] | |||||
Common shares, shares authorized (in shares) | 10,000,000 | 10,000,000 | |||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |||
Common shares, shares outstanding (in shares) | 7,187,500 | 7,187,500 | 7,187,500 | ||
Transferred shares to qualified institutional buyers | 1,650,000 | ||||
Ratio to be applied to the stock in the conversion | 20 | ||||
Numbers of shares surrendered for no consideration | 1,437,500 |
STOCKHOLDERS' EQUITY - Warrants
STOCKHOLDERS' EQUITY - Warrants (Details) | 9 Months Ended | |
Dec. 04, 2021 | Sep. 30, 2022 $ / shares | |
Class of Warrant or Right [Line Items] | ||
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent) | 115% | |
Restrictions on transfer period of time after business combination completion | 30 days | |
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 | ||
Class of Warrant or Right [Line Items] | ||
Redemption trigger price will be adjusted (per share) | $ 18 | |
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent) | 180% | |
Public Warrants | ||
Class of Warrant or Right [Line Items] | ||
Warrant exercise period condition one | 30 days | |
Public Warrants expiration term | 5 years | |
Threshold trading days for redemption of public warrants | 20 days | |
Share Price | $ 9.2 | |
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant | 60 | |
Restrictions on transfer period of time after business combination completion | 30 days | |
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 | ||
Class of Warrant or Right [Line Items] | ||
Redemption price per public warrant (in dollars per share) | $ 0.01 | |
Warrant redemption condition minimum share price | $ 18 | |
Threshold trading days for redemption of public warrants | 20 days | |
Redemption period | 30 days |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - Sponsor - USD ($) | Nov. 30, 2022 | Sep. 30, 2022 | Nov. 30, 2021 |
Subsequent Event [Line Items] | |||
Working Capital Loan Warrant | $ 1,000,000 | $ 1,000,000 | |
Subsequent Event [Member] | |||
Subsequent Event [Line Items] | |||
Working Capital Loan Warrant | $ 1,000,000 |